Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to GLP-1 drugs ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

A new study reports that replacing sugary beverages with artificially sweetened drinks can help promote weight loss, and that ...

A new study identified genetic variants that researchers say can affect pounds lost while taking a GLP-1 drug.

The reason some people on weight-loss jabs shed pounds more easily than others may be because of their DNA, scientists have ...

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...

By Leah Douglas WASHINGTON, April 6 (Reuters) - Americans starting weight-loss medicines for the first time want lower cost ...